NASDAQ:CAPR
$4.12
(
-1.67%
)
Friday, 24th Mar 2023
Capricor Therapeutics Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $4.06 | $5.22 | Friday, 24th Mar 2023 CAPR stock ended at $4.12. This is 1.67% less than the trading day before Thursday, 23rd Mar 2023. During the day the stock fluctuated 5.17% from a day low at $4.06 to a day high of $4.27. |
| 90 days | $3.30 | $5.22 | |
| 52 weeks | $2.81 | $6.58 |
Historical Capricor Therapeutics prices
| Date | Open | High | Low | Close | Volume |
| 2021-06-10 | $4.50 | $4.57 | $4.33 | $4.42 | 181 447 |
| 2021-06-09 | $4.55 | $4.60 | $4.41 | $4.50 | 217 831 |
| 2021-06-08 | $4.35 | $4.77 | $4.35 | $4.47 | 455 946 |
| 2021-06-07 | $3.86 | $4.36 | $3.86 | $4.30 | 334 593 |
| 2021-06-04 | $3.95 | $3.98 | $3.81 | $3.86 | 148 429 |
| 2021-06-03 | $3.90 | $3.99 | $3.81 | $3.90 | 179 962 |
| 2021-06-02 | $3.93 | $3.97 | $3.86 | $3.97 | 201 121 |
| 2021-06-01 | $3.88 | $3.93 | $3.69 | $3.87 | 272 441 |
| 2021-05-28 | $3.70 | $3.84 | $3.69 | $3.79 | 229 093 |
| 2021-05-27 | $3.67 | $3.80 | $3.66 | $3.71 | 168 912 |
| 2021-05-26 | $3.63 | $3.75 | $3.62 | $3.67 | 175 868 |
| 2021-05-25 | $3.67 | $3.75 | $3.62 | $3.65 | 86 627 |
| 2021-05-24 | $3.89 | $3.89 | $3.66 | $3.69 | 163 683 |
| 2021-05-21 | $3.88 | $3.94 | $3.80 | $3.85 | 156 819 |
| 2021-05-20 | $3.87 | $3.94 | $3.73 | $3.81 | 137 307 |
| 2021-05-19 | $3.74 | $3.92 | $3.69 | $3.85 | 129 080 |
| 2021-05-18 | $3.91 | $4.06 | $3.80 | $3.85 | 173 083 |
| 2021-05-17 | $3.60 | $3.93 | $3.60 | $3.87 | 275 931 |
| 2021-05-14 | $3.35 | $3.69 | $3.24 | $3.62 | 637 119 |
| 2021-05-13 | $3.41 | $3.43 | $3.13 | $3.16 | 321 217 |
| 2021-05-12 | $3.64 | $3.64 | $3.35 | $3.39 | 226 228 |
| 2021-05-11 | $3.30 | $3.59 | $3.30 | $3.53 | 442 713 |
| 2021-05-10 | $3.52 | $3.59 | $3.34 | $3.46 | 366 160 |
| 2021-05-07 | $3.39 | $3.56 | $3.37 | $3.47 | 368 674 |
| 2021-05-06 | $3.71 | $3.73 | $3.36 | $3.41 | 650 235 |
| 2021-05-05 | $3.80 | $3.84 | $3.69 | $3.70 | 302 885 |
| 2021-05-04 | $4.23 | $4.23 | $3.75 | $3.80 | 938 049 |
| 2021-05-03 | $4.71 | $4.72 | $4.18 | $4.25 | 504 638 |
| 2021-04-30 | $4.34 | $4.75 | $4.31 | $4.63 | 1 054 382 |
| 2021-04-29 | $4.11 | $5.30 | $4.10 | $4.54 | 8 951 550 |
| 2021-04-28 | $3.96 | $4.02 | $3.90 | $3.95 | 151 820 |
| 2021-04-27 | $4.04 | $4.10 | $3.90 | $3.92 | 239 405 |
| 2021-04-26 | $3.92 | $4.07 | $3.92 | $3.98 | 239 554 |
| 2021-04-23 | $3.99 | $4.06 | $3.85 | $3.92 | 189 784 |
| 2021-04-22 | $3.95 | $4.06 | $3.90 | $3.97 | 135 900 |
| 2021-04-21 | $3.84 | $4.03 | $3.84 | $3.95 | 145 682 |
| 2021-04-20 | $4.02 | $4.04 | $3.85 | $3.85 | 177 681 |
| 2021-04-19 | $4.03 | $4.07 | $3.86 | $3.98 | 254 997 |
| 2021-04-16 | $4.08 | $4.16 | $3.97 | $4.01 | 316 295 |
| 2021-04-15 | $4.22 | $4.22 | $4.00 | $4.02 | 231 060 |
| 2021-04-14 | $4.19 | $4.40 | $4.07 | $4.07 | 158 022 |
| 2021-04-13 | $4.25 | $4.36 | $4.14 | $4.22 | 112 338 |
| 2021-04-12 | $4.36 | $4.45 | $4.11 | $4.24 | 216 878 |
| 2021-04-09 | $4.44 | $4.53 | $4.32 | $4.39 | 109 897 |
| 2021-04-08 | $4.38 | $4.46 | $4.27 | $4.42 | 119 789 |
| 2021-04-07 | $4.39 | $4.59 | $4.30 | $4.37 | 176 802 |
| 2021-04-06 | $4.50 | $4.58 | $4.36 | $4.44 | 170 595 |
| 2021-04-05 | $4.94 | $4.96 | $4.41 | $4.48 | 536 681 |
| 2021-04-01 | $4.73 | $4.85 | $4.68 | $4.83 | 110 464 |
| 2021-03-31 | $4.72 | $4.88 | $4.65 | $4.68 | 224 032 |
About Capricor Therapeutics
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for the treatment of patients with late-stage Duchenne muscular dystrophy (DMD); and CAP-1002, which is in Ph... CAPR Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
